
Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) stock is surging on Monday, with a session volume of 11.67 million compared to the average volume of 408.08 thousand as per data from Benzinga Pro.
Monte Rosa announced a collaboration with Novartis AG (NYSE:NVS) to develop novel degraders for immune-mediated diseases.